American Ginseng Treatment for Multiple Sclerosis Related Fatigue

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

March 31, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

American ginseng extract HT-1001

Ginseng HT-1001 was dosed at 100 mg orally per day initially, increased after one week to 200 mg per day, then further increased the next week to 400 mg per day as tolerated. Subjects were then maintained on 400 mg per day or the maximum tolerated dose for the remainder of the 6 week treatment period.

DRUG

placebo

Placebo capsules were identical to the study drug and were dose escalated to match the study drug. Subjects were maintained on placebo capsules for the remainder of the 6 week treatment period.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

Oregon Health and Science University

OTHER

NCT00754832 - American Ginseng Treatment for Multiple Sclerosis Related Fatigue | Biotech Hunter | Biotech Hunter